Financhill
Sell
31

ELMD Quote, Financials, Valuation and Earnings

Last price:
$24.12
Seasonality move :
-3.4%
Day range:
$23.45 - $24.45
52-week range:
$13.74 - $35.56
Dividend yield:
0%
P/E ratio:
32.25x
P/S ratio:
3.63x
P/B ratio:
4.75x
Volume:
56.8K
Avg. volume:
92.6K
1-year change:
49.14%
Market cap:
$207M
Revenue:
$54.7M
EPS (TTM):
$0.75

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ELMD
Electromed
$15.8M -- 13.91% -- $37.00
AXGN
Axogen
$48.3M $0.02 17.84% -76% $25.71
IRIX
IRIDEX
$12.8M -$0.12 -2.72% -18.18% --
MODD
Modular Medical
-- -$0.12 -- -47.83% $8.00
MYO
Myomo
$9.2M -$0.08 145.61% -24% $9.25
STXS
Stereotaxis
$6.9M -$0.07 -0.07% -20.83% $4.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ELMD
Electromed
$24.19 $37.00 $207M 32.25x $0.00 0% 3.63x
AXGN
Axogen
$17.81 $25.71 $789.8M -- $0.00 0% 4.21x
IRIX
IRIDEX
$0.99 -- $16.5M -- $0.00 0% 0.33x
MODD
Modular Medical
$1.08 $8.00 $43.9M -- $0.00 0% --
MYO
Myomo
$4.85 $9.25 $166.7M -- $0.00 0% 5.63x
STXS
Stereotaxis
$1.71 $4.50 $147M -- $0.00 0% 5.41x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ELMD
Electromed
-- 1.939 -- 4.68x
AXGN
Axogen
31.37% 1.667 6.53% 1.88x
IRIX
IRIDEX
51.25% 1.717 9.47% 0.73x
MODD
Modular Medical
-- -0.213 -- --
MYO
Myomo
-- 2.090 -- 2.82x
STXS
Stereotaxis
-- 1.683 -- 0.74x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ELMD
Electromed
$12.6M $2.5M 15.91% 15.91% 15.64% $2.9M
AXGN
Axogen
$37.6M $2M -6.89% -10.21% 4.56% $7.9M
IRIX
IRIDEX
$4.3M -$1.9M -146.36% -157.91% -16.15% -$3.1M
MODD
Modular Medical
-- -$4.9M -- -- -- -$4.6M
MYO
Myomo
$8.6M -$245.3K -48.64% -48.64% -2.03% $2.5M
STXS
Stereotaxis
$3.2M -$7.6M -139.2% -139.2% -120.3% $1.3M

Electromed vs. Competitors

  • Which has Higher Returns ELMD or AXGN?

    Axogen has a net margin of 12.11% compared to Electromed's net margin of 0.91%. Electromed's return on equity of 15.91% beat Axogen's return on equity of -10.21%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELMD
    Electromed
    77.68% $0.22 $43.6M
    AXGN
    Axogen
    76.06% $0.01 $151.4M
  • What do Analysts Say About ELMD or AXGN?

    Electromed has a consensus price target of $37.00, signalling upside risk potential of 52.96%. On the other hand Axogen has an analysts' consensus of $25.71 which suggests that it could grow by 44.38%. Given that Electromed has higher upside potential than Axogen, analysts believe Electromed is more attractive than Axogen.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELMD
    Electromed
    2 0 0
    AXGN
    Axogen
    5 0 0
  • Is ELMD or AXGN More Risky?

    Electromed has a beta of 0.594, which suggesting that the stock is 40.575% less volatile than S&P 500. In comparison Axogen has a beta of 0.995, suggesting its less volatile than the S&P 500 by 0.487%.

  • Which is a Better Dividend Stock ELMD or AXGN?

    Electromed has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Axogen offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed pays -- of its earnings as a dividend. Axogen pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELMD or AXGN?

    Electromed quarterly revenues are $16.3M, which are smaller than Axogen quarterly revenues of $49.4M. Electromed's net income of $2M is higher than Axogen's net income of $450K. Notably, Electromed's price-to-earnings ratio is 32.25x while Axogen's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed is 3.63x versus 4.21x for Axogen. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELMD
    Electromed
    3.63x 32.25x $16.3M $2M
    AXGN
    Axogen
    4.21x -- $49.4M $450K
  • Which has Higher Returns ELMD or IRIX?

    IRIDEX has a net margin of 12.11% compared to Electromed's net margin of -16.69%. Electromed's return on equity of 15.91% beat IRIDEX's return on equity of -157.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELMD
    Electromed
    77.68% $0.22 $43.6M
    IRIX
    IRIDEX
    37.33% -$0.12 $5.4M
  • What do Analysts Say About ELMD or IRIX?

    Electromed has a consensus price target of $37.00, signalling upside risk potential of 52.96%. On the other hand IRIDEX has an analysts' consensus of -- which suggests that it could grow by 101.86%. Given that IRIDEX has higher upside potential than Electromed, analysts believe IRIDEX is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELMD
    Electromed
    2 0 0
    IRIX
    IRIDEX
    0 0 0
  • Is ELMD or IRIX More Risky?

    Electromed has a beta of 0.594, which suggesting that the stock is 40.575% less volatile than S&P 500. In comparison IRIDEX has a beta of 0.737, suggesting its less volatile than the S&P 500 by 26.316%.

  • Which is a Better Dividend Stock ELMD or IRIX?

    Electromed has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed pays -- of its earnings as a dividend. IRIDEX pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELMD or IRIX?

    Electromed quarterly revenues are $16.3M, which are larger than IRIDEX quarterly revenues of $11.6M. Electromed's net income of $2M is higher than IRIDEX's net income of -$1.9M. Notably, Electromed's price-to-earnings ratio is 32.25x while IRIDEX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed is 3.63x versus 0.33x for IRIDEX. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELMD
    Electromed
    3.63x 32.25x $16.3M $2M
    IRIX
    IRIDEX
    0.33x -- $11.6M -$1.9M
  • Which has Higher Returns ELMD or MODD?

    Modular Medical has a net margin of 12.11% compared to Electromed's net margin of --. Electromed's return on equity of 15.91% beat Modular Medical's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    ELMD
    Electromed
    77.68% $0.22 $43.6M
    MODD
    Modular Medical
    -- -$0.13 --
  • What do Analysts Say About ELMD or MODD?

    Electromed has a consensus price target of $37.00, signalling upside risk potential of 52.96%. On the other hand Modular Medical has an analysts' consensus of $8.00 which suggests that it could grow by 640.74%. Given that Modular Medical has higher upside potential than Electromed, analysts believe Modular Medical is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELMD
    Electromed
    2 0 0
    MODD
    Modular Medical
    1 0 0
  • Is ELMD or MODD More Risky?

    Electromed has a beta of 0.594, which suggesting that the stock is 40.575% less volatile than S&P 500. In comparison Modular Medical has a beta of -4.642, suggesting its less volatile than the S&P 500 by 564.221%.

  • Which is a Better Dividend Stock ELMD or MODD?

    Electromed has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Modular Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed pays -- of its earnings as a dividend. Modular Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELMD or MODD?

    Electromed quarterly revenues are $16.3M, which are larger than Modular Medical quarterly revenues of --. Electromed's net income of $2M is higher than Modular Medical's net income of -$4.8M. Notably, Electromed's price-to-earnings ratio is 32.25x while Modular Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed is 3.63x versus -- for Modular Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELMD
    Electromed
    3.63x 32.25x $16.3M $2M
    MODD
    Modular Medical
    -- -- -- -$4.8M
  • Which has Higher Returns ELMD or MYO?

    Myomo has a net margin of 12.11% compared to Electromed's net margin of -2.16%. Electromed's return on equity of 15.91% beat Myomo's return on equity of -48.64%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELMD
    Electromed
    77.68% $0.22 $43.6M
    MYO
    Myomo
    71.39% -$0.01 $24.7M
  • What do Analysts Say About ELMD or MYO?

    Electromed has a consensus price target of $37.00, signalling upside risk potential of 52.96%. On the other hand Myomo has an analysts' consensus of $9.25 which suggests that it could grow by 90.72%. Given that Myomo has higher upside potential than Electromed, analysts believe Myomo is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELMD
    Electromed
    2 0 0
    MYO
    Myomo
    3 0 0
  • Is ELMD or MYO More Risky?

    Electromed has a beta of 0.594, which suggesting that the stock is 40.575% less volatile than S&P 500. In comparison Myomo has a beta of 1.548, suggesting its more volatile than the S&P 500 by 54.752%.

  • Which is a Better Dividend Stock ELMD or MYO?

    Electromed has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed pays -- of its earnings as a dividend. Myomo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELMD or MYO?

    Electromed quarterly revenues are $16.3M, which are larger than Myomo quarterly revenues of $12.1M. Electromed's net income of $2M is higher than Myomo's net income of -$260.1K. Notably, Electromed's price-to-earnings ratio is 32.25x while Myomo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed is 3.63x versus 5.63x for Myomo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELMD
    Electromed
    3.63x 32.25x $16.3M $2M
    MYO
    Myomo
    5.63x -- $12.1M -$260.1K
  • Which has Higher Returns ELMD or STXS?

    Stereotaxis has a net margin of 12.11% compared to Electromed's net margin of -118.53%. Electromed's return on equity of 15.91% beat Stereotaxis's return on equity of -139.2%.

    Company Gross Margin Earnings Per Share Invested Capital
    ELMD
    Electromed
    77.68% $0.22 $43.6M
    STXS
    Stereotaxis
    50.73% -$0.09 $11.4M
  • What do Analysts Say About ELMD or STXS?

    Electromed has a consensus price target of $37.00, signalling upside risk potential of 52.96%. On the other hand Stereotaxis has an analysts' consensus of $4.50 which suggests that it could grow by 163.16%. Given that Stereotaxis has higher upside potential than Electromed, analysts believe Stereotaxis is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    ELMD
    Electromed
    2 0 0
    STXS
    Stereotaxis
    2 0 0
  • Is ELMD or STXS More Risky?

    Electromed has a beta of 0.594, which suggesting that the stock is 40.575% less volatile than S&P 500. In comparison Stereotaxis has a beta of 1.602, suggesting its more volatile than the S&P 500 by 60.223%.

  • Which is a Better Dividend Stock ELMD or STXS?

    Electromed has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed pays -- of its earnings as a dividend. Stereotaxis pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ELMD or STXS?

    Electromed quarterly revenues are $16.3M, which are larger than Stereotaxis quarterly revenues of $6.3M. Electromed's net income of $2M is higher than Stereotaxis's net income of -$7.5M. Notably, Electromed's price-to-earnings ratio is 32.25x while Stereotaxis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed is 3.63x versus 5.41x for Stereotaxis. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ELMD
    Electromed
    3.63x 32.25x $16.3M $2M
    STXS
    Stereotaxis
    5.41x -- $6.3M -$7.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
100
DLICY alert for Apr 2

Dai-ichi Life Holdings [DLICY] is up 100.91% over the past day.

Buy
78
GATE alert for Apr 2

Marblegate Acquisition [GATE] is up 86.64% over the past day.

Sell
15
PCVX alert for Apr 2

Vaxcyte [PCVX] is down 14.62% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock